280 related articles for article (PubMed ID: 30348783)
21. Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells.
Galperin E; Abdelmoti L; Sorkin A
PLoS One; 2012; 7(5):e36469. PubMed ID: 22606262
[TBL] [Abstract][Full Text] [Related]
22. A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.
Kwon JJ; Hahn WC
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526449
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
Komatsuzaki S; Aoki Y; Niihori T; Okamoto N; Hennekam RC; Hopman S; Ohashi H; Mizuno S; Watanabe Y; Kamasaki H; Kondo I; Moriyama N; Kurosawa K; Kawame H; Okuyama R; Imaizumi M; Rikiishi T; Tsuchiya S; Kure S; Matsubara Y
J Hum Genet; 2010 Dec; 55(12):801-9. PubMed ID: 20882035
[TBL] [Abstract][Full Text] [Related]
24. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions.
Jaumot M; Hancock JF
Oncogene; 2001 Jul; 20(30):3949-58. PubMed ID: 11494123
[TBL] [Abstract][Full Text] [Related]
26. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
[TBL] [Abstract][Full Text] [Related]
27. Two Japanese patients with Noonan syndrome-like disorder with loose anagen hair 2.
Maruwaka K; Nakajima Y; Yamada T; Tanaka T; Kosaki R; Inagaki H; Kosaki K; Kurahashi H
Am J Med Genet A; 2022 Jul; 188(7):2246-2250. PubMed ID: 35338599
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic and neural crest defects in zebrafish shoc2 mutants: a novel vertebrate model for Noonan-like syndrome.
Jang H; Oakley E; Forbes-Osborne M; Kesler MV; Norcross R; Morris AC; Galperin E
Hum Mol Genet; 2019 Feb; 28(3):501-514. PubMed ID: 30329053
[TBL] [Abstract][Full Text] [Related]
29. Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling.
Kaduwal S; Jeong WJ; Park JC; Lee KH; Lee YM; Jeon SH; Lim YB; Min do S; Choi KY
Oncotarget; 2015 Oct; 6(32):33091-105. PubMed ID: 26384305
[TBL] [Abstract][Full Text] [Related]
30. RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
Bonsor DA; Simanshu DK
Annu Rev Cancer Biol; 2024 Jun; 8():97-113. PubMed ID: 38882927
[TBL] [Abstract][Full Text] [Related]
31. Generation of a genetically-modified induced pluripotent stem cell line harboring a Noonan syndrome-associated gene variant MRAS p.G23V.
Busley AV; Cyganek L
Stem Cell Res; 2023 Jun; 69():103108. PubMed ID: 37141804
[TBL] [Abstract][Full Text] [Related]
32. Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5.
Jang ER; Jang H; Shi P; Popa G; Jeoung M; Galperin E
J Cell Sci; 2015 Dec; 128(23):4428-41. PubMed ID: 26519477
[TBL] [Abstract][Full Text] [Related]
33. A Novel SHOC2 Variant in Rasopathy.
Hannig V; Jeoung M; Jang ER; Phillips JA; Galperin E
Hum Mutat; 2014 Nov; 35(11):1290-4. PubMed ID: 25137548
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair.
Ferrero GB; Picco G; Baldassarre G; Flex E; Isella C; Cantarella D; Corà D; Chiesa N; Crescenzio N; Timeus F; Merla G; Mazzanti L; Zampino G; Rossi C; Silengo M; Tartaglia M; Medico E
Hum Mutat; 2012 Apr; 33(4):703-9. PubMed ID: 22253195
[TBL] [Abstract][Full Text] [Related]
35. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.
Cordeddu V; Di Schiavi E; Pennacchio LA; Ma'ayan A; Sarkozy A; Fodale V; Cecchetti S; Cardinale A; Martin J; Schackwitz W; Lipzen A; Zampino G; Mazzanti L; Digilio MC; Martinelli S; Flex E; Lepri F; Bartholdi D; Kutsche K; Ferrero GB; Anichini C; Selicorni A; Rossi C; Tenconi R; Zenker M; Merlo D; Dallapiccola B; Iyengar R; Bazzicalupo P; Gelb BD; Tartaglia M
Nat Genet; 2009 Sep; 41(9):1022-6. PubMed ID: 19684605
[TBL] [Abstract][Full Text] [Related]
36. Caenorhabditis elegans CNK-1 promotes Raf activation but is not essential for Ras/Raf signaling.
Rocheleau CE; Rönnlund A; Tuck S; Sundaram MV
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11757-62. PubMed ID: 16085714
[TBL] [Abstract][Full Text] [Related]
37. Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling.
Molzan M; Schumacher B; Ottmann C; Baljuls A; Polzien L; Weyand M; Thiel P; Rose R; Rose M; Kuhenne P; Kaiser M; Rapp UR; Kuhlmann J; Ottmann C
Mol Cell Biol; 2010 Oct; 30(19):4698-711. PubMed ID: 20679480
[TBL] [Abstract][Full Text] [Related]
38. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
[TBL] [Abstract][Full Text] [Related]
39. Nutritional aspects of Noonan syndrome and Noonan-related disorders.
da Silva FM; Jorge AA; Malaquias A; da Costa Pereira A; Yamamoto GL; Kim CA; Bertola D
Am J Med Genet A; 2016 Jun; 170(6):1525-31. PubMed ID: 27038324
[TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.
Kobayashi T; Aoki Y; Niihori T; Cavé H; Verloes A; Okamoto N; Kawame H; Fujiwara I; Takada F; Ohata T; Sakazume S; Ando T; Nakagawa N; Lapunzina P; Meneses AG; Gillessen-Kaesbach G; Wieczorek D; Kurosawa K; Mizuno S; Ohashi H; David A; Philip N; Guliyeva A; Narumi Y; Kure S; Tsuchiya S; Matsubara Y
Hum Mutat; 2010 Mar; 31(3):284-94. PubMed ID: 20052757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
